A FTSE 250 tech growth stock I’d buy after this 10% price crash

I think this FTSE 250 (INDEXFTSE: MCX) growth stock looks very tempting, despite one broker’s downgrade.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve been following my Fool colleague Edward Sheldon’s thoughts on cyber-security firm Avast (LSE: AVST) recently. One broker has just lifted its target price by an impressive 38%, and that’s an eye opener.

You can imagine my surprise, then, when I saw Avast briefly heading the table of fallers Wednesday. The shares shed 10.5% in early trading, though they’re back to a 4.7% drop at the time of writing, at 459p.

That followed a weak day Tuesday too, when Avast shares lost 9% of their value, so what’s happening to this potential growth stock? It seems broker Peel Hunt came out with a ‘sell’ rating later on the day, setting its target price as low as 405p. If it’s right, we should expect the Avast price to drop by a further 11-12%.

Threat

Avast’s software is apparently installed on around 35% of Windows PCs outside of China, and it seems to have built some effective barriers to entry. Peel Hunt, however, apparently sees a threat to Avast from Microsoft‘s own cyber-safety developments, which it deems to be significant.

I might be cynical, but Microsoft really hasn’t impressed the world with its own software security in the decades it’s been operating. And I don’t see an end to the need for third-party PC security solutions any time soon.

Despite Peel Hunt’s bearish stance, the analyst consensus still suggests a strong buy. And I see a forward P/E of around 20 as a reasonable growth valuation.

I’m standing back and watching, at least until full-year results due 26 February. But I’m cautiously optimistic over Avast.

Jump

Meanwhile, I was pleased to see Crest Nicholson (LSE: CRST) shares gaining 5% the day after Tuesday’s full-year results. That’s a 12% rise in two days so far, with the price up 37% over the past year.

I’ve been enthusiastic over housebuilders for some time now, but Crest’s 12-month performance has exceeded my expectations. By comparison, shares in Taylor Wimpey (Britain’s biggest) are up 31% over 12 months, with Persimmon up 27%.

On the face of it, Crest’s results looked a little weak, with sales down 2.5% and adjusted pre-tax profit down 28%. But that was largely expected, and I’m seeing encouraging progress in the company’s strategy for future growth. Crest maintained its dividend at 33p per share after “strong cash generation and disciplined capital allocation.

Cash

Net cash grew by 164% to £37.2m, so I think future dividends should be safe. Chief executive Peter Truscott said: “Crest Nicholson is a resilient business with a bright future. I am confident that our updated strategy will restore Crest Nicholson to being one of the UK’s leading house builders.

The firm also believes the general election outcome should be good for the sector, and I agree. As long as we avoid a no-deal Brexit catastrophe, I can see housing demand remaining reasonably robust.

Crest Nicholson shares are on a 2020 P/E of 14, dropping to 12.5 on 2021 forecasts. With forecast dividend yields of 6.7%, I rate the stock as buy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. Alan Oscroft owns shares of Persimmon. The Motley Fool UK owns shares of and has recommended Microsoft and recommends the following options: long January 2021 $85 calls on Microsoft and short January 2021 $115 calls on Microsoft. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »